French pharma giant Sanofi halts work on mRNA Covid-19 vaccine


French pharmaceutical group Sanofi has announced it is halting work on developing a Covid-19 vaccine using mRNA messenger technology because of the abundance of supplies of similar vaccines from other firms, and will instead develope mRNA vaccines against other pathogens, including the flu.

Reading articles is for subscribers only. Subscribe now.

French pharmaceutical giant Sanofi said on Tuesday it was stopping work on an mRNA vaccine against Covid-19 despite positive test results as it lags behind rivals on producing a coronavirus shot, reports CNA.